IQVIA™ Real-World Insights Bibliography

Use of postmenopausal hormone therapy and risk of Alzheimer?s disease in Finland: nationwide case-control study
Author(s): Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.
Affiliations(s): EPID Research Oy, Espoo, Finland
Publication(s):  BMJ
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Mental health,
2019
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse
Author(s): Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS
Affiliations(s): EPID Research Oy, Espoo, Finland
Publication(s):  Menopause
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Patient Registries & Real-World Study Methods,
2019
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy
Author(s): Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS
Affiliations(s): EPID Research Oy, Espoo, Finland
Publication(s):  Int Urogynecol J
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Patient Registries & Real-World Study Methods,
2019
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
CLUE: Consequences for life of children with in utero exposure to metformin in Finland
Author(s): Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch, Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Affiliations(s): Merck KGaA: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch IQVIA (SF-EPID): Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Publication(s):  The International Diabetes Federation (IDF) Congress 2019
Document Type(s): Oral presentation,
Countries: Finland,
C:
Y:
Diabetes,
2019
  L:
A:
English
Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Public Health, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Author(s): Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations(s): 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publication(s):  ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Type(s): Oral presentation,
Countries: Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe
Author(s): Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA
Affiliations(s): Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA
Publication(s):  34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Type(s): Abstract,
Countries: Denmark, Finland, Germany, Norway, Sweden, UK,
C:
Y:
Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods,
2018
  L:
A:
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review,
  Add to report
 
 
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder
Author(s): Lähteenvuo M, Tanskanen A, Taipale H
Affiliations(s): Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland
Publication(s):  JAMA Psychiatry (2018); 75(4):347-355
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Mental health,
2018
  L:
A:
English
Prospective study,
  Add to report
 
 
Different patterns of second?line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Author(s): Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW
Affiliations(s): StatFinn & EPID Research, Espoo, Finland
Publication(s):  Endocrinol Diabetes Metab.
Document Type(s): Article,
Countries: Denmark, Finland, Norway, Sweden,
Click here for the abstract
C:
Y:
Diabetes,
2018
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults
Author(s): Strandberg AY, Khanfir H, Mäkimattila S, Saukkonen T, Strandberg TE, Hoti F
Affiliations(s): University of Helsinki, Clinicum, Helsinki, Finland, Aava Medical Centre, Kerava, Finland
Publication(s):  Ann Med. (2017) 49(4):357-364
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Diabetes,
2017
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
Author(s): Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7
Affiliations(s): 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany
Publication(s):  JHEOR 2017;5(1):89-108
Document Type(s): Article,
Countries: Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK,
C:
Y:
Immunology and Vaccination, Infectious disease, Respiratory disease,
2017
  L:
A:
English
Epidemiological study, Public Health,
  Add to report
 
 
 1 of 8 Next Page Last Page